ABSTRACT
Background: Dysfunctional uterine bleeding [DUB] is one of the commonest condition for which patient seeks out medical consultation. The prevalence increases with the increase of age peaking before menopause
Objective: The aim of this work is to evaluate the effect of this new form of levonorgestrel-releasing IUD on the treatment of patients with abnormal uterine bleeding
Subjects and methods: A prospective age-specific comparative analysis of 61 peri-menopausal women presented with dysfunctional uterine bleeding who constituted the study group. They underwent hysteroscopy and endometrial sampling during an 18 months period from June 2014 to January 2016 at Ain Shams University Materity Hospital. Prior to metraplant-E application, all the patients in this study were in the age of 25-58 years old
Results: The role of Metraplant-E in the treatment of abnormal uterine bleeding [AUB] was evaluated. Sixty-one women with failed attempt[s] of medical treatment unwilling or unfit for hysterectomy were treated with Metaplant-E. Menstrual blood loss was assessed by pictoral bleeding assessment chart [PBAC], bleeding index [B.I] and total bleeding score [T.B.S/month]. The bleeding patterns in the form of the mean menstrual blood loss estimated by bleeding index and the mean menstrual loss estimated by the total bleeding score/month and PBAC decreased significantly [p = 0.001]. The quality of life scale [Likert scale] improved significantly [p = 0.001]. All 15 cases who had endometrial sampling demonstrated progestational effect on histo-pathological examination
Conclusion: Metraplant-E was found to be effective in managing dysfunctional menorrhagia on both clinical and histopathological levels
ABSTRACT
This study included two groups of full term pregnant candidate for induction of labor with unripe cervix. In group I [n = 35], cervical ripening is carried out by dinoprostone 3 mg in the posterior vaginal fornix and another dose may be applied six hours later if needed. Moreover, in group II [n=35], cervical ripening by intracervical Foley's catheter under traction with the balloon inflated after it passes the internal os. Patients of both groups were compared regarding the changes in bishop score, ripening and delivery times, route of delivery and any recorded fetal or maternal complications. A significant improvement in bishop score is achieved with Foley's catheter; yet the improvement in the score with dinoprostone was better and also a significant shorter ripening time. The total delivery time was nearly the same in both groups. Less maternal and fetal complications were recorded in the catheter group. The study concluded that intracervical Foley's catheter can be considered as a safe and cheap method for preinduction cervical ripening, especially in situations when prostaglandins can not be used